A Five-Gene Peripheral Blood Diagnostic Test for Acute Rejection in Renal Transplantation

Autor: Vikas R. Dharnidharka, Amery Chen, Tara K. Sigdel, David B. Kershaw, M. Zhang, Minnie M. Sarwal, Bradley A. Warady, Rong Chen, Robert B. Ettenger, Oscar Salvatierra, Ruth A. McDonald, V. M. Vehaskari, Hong Dai, Tim Q. Tran, Szu-Chuan Hsieh, M. Vitalone, Valeriya Zarkhin, Rasika A. Mathias, Poonam Sansanwal, Wenzhong Xiao, Purvesh Khatri, M. Benfield, Anthony A. Portale, Maarten Naesens, Ronald W. Davis, Lihua Ying, Atul J. Butte, Michael N. Mindrinos, H. J. Baluarte, Li Li, Elaine S. Kamil, William E. Harmon
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Oncology
Graft Rejection
Pathology
Kidney Disease
Single Center
Polymerase Chain Reaction
Medical and Health Sciences
Acute allograft rejection
Immunology and Allergy
Medicine
Pharmacology (medical)
Prospective cohort study
Kidney transplantation
Pediatric
screening and diagnosis
medicine.diagnostic_test
transplant rejection
bioinformatics
renal transplantation
Transplant rejection
Detection
Acute Disease
biomarker
Biomarker (medicine)
Renal biopsy
Biotechnology
4.2 Evaluation of markers and technologies
medicine.medical_specialty
Renal and urogenital
Sensitivity and Specificity
renal allograft rejection
Article
Rare Diseases
Clinical Research
Internal medicine
Biopsy
Genetics
Humans
Transplantation
business.industry
Organ Transplantation
medicine.disease
Kidney Transplantation
4.1 Discovery and preclinical testing of markers and technologies
transplantation genomics
translational research
Surgery
business
Zdroj: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol 12, iss 10
Popis: Monitoring of renal graft status through peripheral blood (PB) rather than invasive biopsy is important as it will lessen the risk of infection and other stresses, while reducing the costs of rejection diagnosis. Blood gene biomarker panels were discovered by microarrays at a single center and subsequently validated and cross-validated by QPCR in the NIH SNSO1 randomized study from 12 US pediatric transplant programs. A total of 367 unique human PB samples, each paired with a graft biopsy for centralized, blinded phenotype classification, were analyzed (115 acute rejection (AR), 180 stable and 72 other causes of graft injury). Of the differentially expressed genes by microarray, Q-PCR analysis of a five gene-set (DUSP1, PBEF1, PSEN1, MAPK9 and NKTR) classified AR with high accuracy. A logistic regression model was built on independent training-set (n = 47) and validated on independent test-set (n = 198)samples, discriminating AR from STA with 91% sensitivity and 94% specificity and AR from all other non-AR phenotypes with 91% sensitivity and 90% specificity. The 5-gene set can diagnose AR potentially avoiding the need for invasive renal biopsy. These data support the conduct of a prospective study to validate the clinical predictive utility of this diagnostic tool.
Databáze: OpenAIRE